Moxetumomab Pasudotox-tdfk and Retrovir Intravenous
Determining the interaction of Moxetumomab Pasudotox-tdfk and Retrovir Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: zidovudine
Brand name: Retrovir
Synonyms: Retrovir (oral/injection), Retrovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Retrovir oral/injection
- Moxetumomab Pasudotox-tdfk-Revatio
- Moxetumomab Pasudotox-tdfk-Revatio Injection
- Moxetumomab Pasudotox-tdfk-Revatio Intravenous
- Moxetumomab Pasudotox-tdfk-Revefenacin
- Moxetumomab Pasudotox-tdfk-Revefenacin inhalation
- Retrovir Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Retrovir Intravenous-Moxifloxacin
- Retrovir Intravenous-Moxifloxacin (Systemic)
- Retrovir Intravenous-Moxifloxacin Hydrochloride
- Retrovir Intravenous-Moxifloxacin Injection
- Retrovir Intravenous-Moxifloxacin Intravenous